0001144204-14-053582.txt : 20140829
0001144204-14-053582.hdr.sgml : 20140829
20140829210023
ACCESSION NUMBER: 0001144204-14-053582
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20140827
FILED AS OF DATE: 20140829
DATE AS OF CHANGE: 20140829
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: INTERCEPT PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0001270073
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 223868459
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 450 W. 15TH STREET
STREET 2: SUITE 505
CITY: NEW YORK
STATE: NY
ZIP: 10011
BUSINESS PHONE: 646-747-1000
MAIL ADDRESS:
STREET 1: 450 W. 15TH STREET
STREET 2: SUITE 505
CITY: New York
STATE: NY
ZIP: 10011
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Shapiro David
CENTRAL INDEX KEY: 0001559570
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35668
FILM NUMBER: 141076262
MAIL ADDRESS:
STREET 1: C/O INTERCEPT PHARMACEUTICALS, INC.
STREET 2: 18 DESBROSSES ST.
CITY: NEW YORK
STATE: NY
ZIP: 10013
4
1
v388035_4.xml
OWNERSHIP DOCUMENT
X0306
4
2014-08-27
0
0001270073
INTERCEPT PHARMACEUTICALS INC
ICPT
0001559570
Shapiro David
C/O INTERCEPT PHARMACEUTICALS, INC.
450 W. 15TH STREET, SUITE 505
NEW YORK
NY
10011
0
1
0
0
CMO and EVP - Development
Common Stock
2014-08-27
4
M
0
10000
8.6667
A
24253
D
Common Stock
2014-08-27
4
S
0
3850
293.0475
D
20403
D
Common Stock
2014-08-27
4
S
0
4250
293.8883
D
16153
D
Common Stock
2014-08-27
4
S
0
1200
295.6099
D
14953
D
Common Stock
2014-08-27
4
S
0
700
296.1364
D
14253
D
Options to Purchase Common Stock
8.6667
2014-08-27
4
M
0
10000
0
D
2020-07-20
Common Stock
10000
30131
D
All shares underlying this option have vested.
This transaction was executed in multiple trades at prices ranging from $292.37 to $293.36. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
This transaction was executed in multiple trades at prices ranging from $293.5 to $294.5. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
This transaction was executed in multiple trades at prices ranging from $295.03 to $296.01. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
This transaction was executed in multiple trades at prices ranging from $296.115 to $296.185. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
/s/ Bryan Yoon, as attorney-in-fact
2014-08-29